0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global H1N1 ELISA Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-9E17023
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global H1N1 ELISA Kits Market Research Report 2024
BUY CHAPTERS

Global H1N1 ELISA Kits Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-9E17023
Report
November 2025
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

H1N1 ELISA Kits Market

The global H1N1 ELISA Kits market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
H1N1 ELISA Kits are diagnostic test kits used to detect the presence of H1N1 influenza virus in patient samples. H1N1 influenza, commonly known as swine flu, is a subtype of the influenza A virus. ELISA, or enzyme-linked immunosorbent assay, is a technique used to identify and quantify specific proteins or antibodies in a sample. H1N1 ELISA Kits utilize antibodies that specifically bind to H1N1 antigens, allowing for the detection and diagnosis of H1N1 influenza infections. These kits provide a sensitive, reliable, and rapid method for identifying H1N1 virus in patient samples, enabling timely treatment and public health interventions.
The industry trend for H1N1 ELISA Kits is influenced by the global occurrences of seasonal and pandemic H1N1 influenza outbreaks. The demand for these kits is expected to fluctuate based on the frequency and severity of H1N1 influenza outbreaks. Factors such as increased global travel, climate changes, and population susceptibility to H1N1 viruses can impact market demand. Innovations in ELISA technology, improvements in kit performance, and the development of multiplex assays for simultaneous detection of multiple influenza strains are anticipated trends for H1N1 ELISA Kits. Additionally, collaborations between diagnostic kit manufacturers and public health agencies may also shape industry trends.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global H1N1 ELISA Kits market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of H1N1 ELISA Kits Market Report

Report Metric Details
Report Name H1N1 ELISA Kits Market
Segment by Type
  • IgM
  • IgG
Segment by Application
  • Hospital
  • Clinic
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company MyBioSource, Sino Biological, Novus Biologicals, Abnova
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the H1N1 ELISA Kits study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the H1N1 ELISA Kits Market report?

Ans: The main players in the H1N1 ELISA Kits Market are MyBioSource, Sino Biological, Novus Biologicals, Abnova

What are the Application segmentation covered in the H1N1 ELISA Kits Market report?

Ans: The Applications covered in the H1N1 ELISA Kits Market report are Hospital, Clinic

What are the Type segmentation covered in the H1N1 ELISA Kits Market report?

Ans: The Types covered in the H1N1 ELISA Kits Market report are IgM, IgG

1 Study Coverage
1.1 Introduction to H1N1 ELISA Kits: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global H1N1 ELISA Kits Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 IgM
1.2.3 IgG
1.3 Market Segmentation by Application
1.3.1 Global H1N1 ELISA Kits Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global H1N1 ELISA Kits Revenue Estimates and Forecasts 2020-2031
2.2 Global H1N1 ELISA Kits Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global H1N1 ELISA Kits Sales Estimates and Forecasts 2020-2031
2.4 Global H1N1 ELISA Kits Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global H1N1 ELISA Kits Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global H1N1 ELISA Kits Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 IgM Market Size by Manufacturers
3.5.2 IgG Market Size by Manufacturers
3.6 Global H1N1 ELISA Kits Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global H1N1 ELISA Kits Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global H1N1 ELISA Kits Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global H1N1 ELISA Kits Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global H1N1 ELISA Kits Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America H1N1 ELISA Kits Sales and Revenue by Type (2020-2031)
6.4 North America H1N1 ELISA Kits Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America H1N1 ELISA Kits Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe H1N1 ELISA Kits Sales and Revenue by Type (2020-2031)
7.4 Europe H1N1 ELISA Kits Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe H1N1 ELISA Kits Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific H1N1 ELISA Kits Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific H1N1 ELISA Kits Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific H1N1 ELISA Kits Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America H1N1 ELISA Kits Sales and Revenue by Type (2020-2031)
9.4 Central and South America H1N1 ELISA Kits Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America H1N1 ELISA Kits Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa H1N1 ELISA Kits Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa H1N1 ELISA Kits Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa H1N1 ELISA Kits Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 MyBioSource
11.1.1 MyBioSource Corporation Information
11.1.2 MyBioSource Business Overview
11.1.3 MyBioSource H1N1 ELISA Kits Product Models, Descriptions and Specifications
11.1.4 MyBioSource H1N1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 MyBioSource H1N1 ELISA Kits Sales by Product in 2024
11.1.6 MyBioSource H1N1 ELISA Kits Sales by Application in 2024
11.1.7 MyBioSource H1N1 ELISA Kits Sales by Geographic Area in 2024
11.1.8 MyBioSource H1N1 ELISA Kits SWOT Analysis
11.1.9 MyBioSource Recent Developments
11.2 Sino Biological
11.2.1 Sino Biological Corporation Information
11.2.2 Sino Biological Business Overview
11.2.3 Sino Biological H1N1 ELISA Kits Product Models, Descriptions and Specifications
11.2.4 Sino Biological H1N1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Sino Biological H1N1 ELISA Kits Sales by Product in 2024
11.2.6 Sino Biological H1N1 ELISA Kits Sales by Application in 2024
11.2.7 Sino Biological H1N1 ELISA Kits Sales by Geographic Area in 2024
11.2.8 Sino Biological H1N1 ELISA Kits SWOT Analysis
11.2.9 Sino Biological Recent Developments
11.3 Novus Biologicals
11.3.1 Novus Biologicals Corporation Information
11.3.2 Novus Biologicals Business Overview
11.3.3 Novus Biologicals H1N1 ELISA Kits Product Models, Descriptions and Specifications
11.3.4 Novus Biologicals H1N1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Novus Biologicals H1N1 ELISA Kits Sales by Product in 2024
11.3.6 Novus Biologicals H1N1 ELISA Kits Sales by Application in 2024
11.3.7 Novus Biologicals H1N1 ELISA Kits Sales by Geographic Area in 2024
11.3.8 Novus Biologicals H1N1 ELISA Kits SWOT Analysis
11.3.9 Novus Biologicals Recent Developments
11.4 Abnova
11.4.1 Abnova Corporation Information
11.4.2 Abnova Business Overview
11.4.3 Abnova H1N1 ELISA Kits Product Models, Descriptions and Specifications
11.4.4 Abnova H1N1 ELISA Kits Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Abnova H1N1 ELISA Kits Sales by Product in 2024
11.4.6 Abnova H1N1 ELISA Kits Sales by Application in 2024
11.4.7 Abnova H1N1 ELISA Kits Sales by Geographic Area in 2024
11.4.8 Abnova H1N1 ELISA Kits SWOT Analysis
11.4.9 Abnova Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 H1N1 ELISA Kits Industry Chain
12.2 H1N1 ELISA Kits Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 H1N1 ELISA Kits Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 H1N1 ELISA Kits Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 H1N1 ELISA Kits Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global H1N1 ELISA Kits Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global H1N1 ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global H1N1 ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global H1N1 ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global H1N1 ELISA Kits Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global H1N1 ELISA Kits Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global H1N1 ELISA Kits Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global H1N1 ELISA Kits Sales by Region (2020-2025) & (K Units)
 Table 8. Global H1N1 ELISA Kits Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global H1N1 ELISA Kits Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global H1N1 ELISA Kits Sales Share by Manufacturers (2020-2025)
 Table 12. Global H1N1 ELISA Kits Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global H1N1 ELISA Kits Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global H1N1 ELISA Kits by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in H1N1 ELISA Kits as of 2024)
 Table 16. Global H1N1 ELISA Kits Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global H1N1 ELISA Kits Average Selling Price (ASP) by Manufacturers (2020-2025) & (K US$/Unit)
 Table 18. Key Manufacturers H1N1 ELISA Kits Manufacturing Base and Headquarters
 Table 19. Global H1N1 ELISA Kits Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global H1N1 ELISA Kits Sales by Type (2020-2025) & (K Units)
 Table 23. Global H1N1 ELISA Kits Sales by Type (2026-2031) & (K Units)
 Table 24. Global H1N1 ELISA Kits Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global H1N1 ELISA Kits Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global H1N1 ELISA Kits ASP by Type (2020-2031) & (K US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global H1N1 ELISA Kits Sales by Application (2020-2025) & (K Units)
 Table 29. Global H1N1 ELISA Kits Sales by Application (2026-2031) & (K Units)
 Table 30. H1N1 ELISA Kits High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global H1N1 ELISA Kits Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global H1N1 ELISA Kits Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global H1N1 ELISA Kits ASP by Application (2020-2031) & (K US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America H1N1 ELISA Kits Growth Accelerators and Market Barriers
 Table 37. North America H1N1 ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America H1N1 ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe H1N1 ELISA Kits Growth Accelerators and Market Barriers
 Table 40. Europe H1N1 ELISA Kits Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe H1N1 ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific H1N1 ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific H1N1 ELISA Kits Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific H1N1 ELISA Kits Growth Accelerators and Market Barriers
 Table 45. Southeast Asia H1N1 ELISA Kits Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America H1N1 ELISA Kits Investment Opportunities and Key Challenges
 Table 47. Central and South America H1N1 ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa H1N1 ELISA Kits Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa H1N1 ELISA Kits Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. MyBioSource Corporation Information
 Table 51. MyBioSource Description and Major Businesses
 Table 52. MyBioSource Product Models, Descriptions and Specifications
 Table 53. MyBioSource Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 54. MyBioSource Sales Value Proportion by Product in 2024
 Table 55. MyBioSource Sales Value Proportion by Application in 2024
 Table 56. MyBioSource Sales Value Proportion by Geographic Area in 2024
 Table 57. MyBioSource H1N1 ELISA Kits SWOT Analysis
 Table 58. MyBioSource Recent Developments
 Table 59. Sino Biological Corporation Information
 Table 60. Sino Biological Description and Major Businesses
 Table 61. Sino Biological Product Models, Descriptions and Specifications
 Table 62. Sino Biological Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 63. Sino Biological Sales Value Proportion by Product in 2024
 Table 64. Sino Biological Sales Value Proportion by Application in 2024
 Table 65. Sino Biological Sales Value Proportion by Geographic Area in 2024
 Table 66. Sino Biological H1N1 ELISA Kits SWOT Analysis
 Table 67. Sino Biological Recent Developments
 Table 68. Novus Biologicals Corporation Information
 Table 69. Novus Biologicals Description and Major Businesses
 Table 70. Novus Biologicals Product Models, Descriptions and Specifications
 Table 71. Novus Biologicals Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 72. Novus Biologicals Sales Value Proportion by Product in 2024
 Table 73. Novus Biologicals Sales Value Proportion by Application in 2024
 Table 74. Novus Biologicals Sales Value Proportion by Geographic Area in 2024
 Table 75. Novus Biologicals H1N1 ELISA Kits SWOT Analysis
 Table 76. Novus Biologicals Recent Developments
 Table 77. Abnova Corporation Information
 Table 78. Abnova Description and Major Businesses
 Table 79. Abnova Product Models, Descriptions and Specifications
 Table 80. Abnova Sales (K Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 81. Abnova Sales Value Proportion by Product in 2024
 Table 82. Abnova Sales Value Proportion by Application in 2024
 Table 83. Abnova Sales Value Proportion by Geographic Area in 2024
 Table 84. Abnova H1N1 ELISA Kits SWOT Analysis
 Table 85. Abnova Recent Developments
 Table 86. Key Raw Materials Distribution
 Table 87. Raw Materials Key Suppliers
 Table 88. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 89. Milestones in Production Technology Evolution
 Table 90. Distributors List
 Table 91. Market Trends and Market Evolution
 Table 92. Market Drivers and Opportunities
 Table 93. Market Challenges, Risks, and Restraints
 Table 94. Research Programs/Design for This Report
 Table 95. Key Data Information from Secondary Sources
 Table 96. Key Data Information from Primary Sources


List of Figures
 Figure 1. H1N1 ELISA Kits Product Picture
 Figure 2. Global H1N1 ELISA Kits Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. IgM Product Picture
 Figure 4. IgG Product Picture
 Figure 5. Global H1N1 ELISA Kits Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Clinic
 Figure 8. H1N1 ELISA Kits Report Years Considered
 Figure 9. Global H1N1 ELISA Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 11. Global H1N1 ELISA Kits Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global H1N1 ELISA Kits Revenue Market Share by Region (2020-2031)
 Figure 13. Global H1N1 ELISA Kits Sales (2020-2031) & (K Units)
 Figure 14. Global H1N1 ELISA Kits Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 15. Global H1N1 ELISA Kits Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers H1N1 ELISA Kits Sales Volume Market Share in 2024
 Figure 17. Global H1N1 ELISA Kits Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. IgM Revenue Market Share by Manufacturer in 2024
 Figure 20. IgG Revenue Market Share by Manufacturer in 2024
 Figure 21. Global H1N1 ELISA Kits Sales Market Share by Type (2020-2031)
 Figure 22. Global H1N1 ELISA Kits Revenue Market Share by Type (2020-2031)
 Figure 23. Global H1N1 ELISA Kits Sales Market Share by Application (2020-2031)
 Figure 24. Global H1N1 ELISA Kits Revenue Market Share by Application (2020-2031)
 Figure 25. North America H1N1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 26. North America H1N1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers H1N1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 28. North America H1N1 ELISA Kits Sales Volume (K Units) by Type (2020- 2031)
 Figure 29. North America H1N1 ELISA Kits Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America H1N1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 31. North America H1N1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe H1N1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 36. Europe H1N1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers H1N1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 38. Europe H1N1 ELISA Kits Sales Volume (K Units) by Type (2020-2031)
 Figure 39. Europe H1N1 ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe H1N1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 41. Europe H1N1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 43. France H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific H1N1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 48. Asia-Pacific H1N1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers H1N1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific H1N1 ELISA Kits Sales Volume (K Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific H1N1 ELISA Kits Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific H1N1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 53. Asia-Pacific H1N1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 58. India H1N1 ELISA Kits Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America H1N1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 60. Central and South America H1N1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers H1N1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America H1N1 ELISA Kits Sales Volume (K Units) by Type (2021-2031)
 Figure 63. Central and South America H1N1 ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America H1N1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 65. Central and South America H1N1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil H1N1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina H1N1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa H1N1 ELISA Kits Sales YoY (2020-2031) & (K Units)
 Figure 69. Middle East and Africa H1N1 ELISA Kits Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers H1N1 ELISA Kits Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa H1N1 ELISA Kits Sales Volume (K Units) by Type (2021-2031)
 Figure 72. South America H1N1 ELISA Kits Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa H1N1 ELISA Kits Sales Volume (K Units) by Application (2020-2031)
 Figure 74. Middle East and Africa H1N1 ELISA Kits Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries H1N1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey H1N1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt H1N1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa H1N1 ELISA Kits Revenue (2020-2025) & (US$ Million)
 Figure 79. H1N1 ELISA Kits Industry Chain Mapping
 Figure 80. Regional H1N1 ELISA Kits Manufacturing Base Distribution (%)
 Figure 81. Global H1N1 ELISA Kits Production Market Share by Region (2020-2031)
 Figure 82. H1N1 ELISA Kits Production Process
 Figure 83. Regional H1N1 ELISA Kits Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global Feline Infectious Peritonitis (FIP) Antivirals Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4U20267
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global Anticoccidial Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-16R16865
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Bacterial Enteric Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-3F17301
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Whooping Cough Vaccination Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-4B20221
Wed Nov 12 00:00:00 UTC 2025

Add to Cart